Cargando…

CDK5 Inhibition Abrogates TNBC Stem‐Cell Property and Enhances Anti‐PD‐1 Therapy

Triple‐negative breast cancer (TNBC) is the most aggressive subtype of breast cancer, in which the higher frequency of cancer stem cells (CSCs) correlates with the poor clinical outcome. An aberrant activation of CDK5 is found to associate with TNBC progression closely. CDK5 mediates PPARγ phosphory...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bei, Yuncheng, Cheng, Nan, Chen, Ting, Shu, Yuxin, Yang, Ye, Yang, Nanfei, Zhou, Xinyu, Liu, Baorui, Wei, Jia, Liu, Qin, Zheng, Wei, Zhang, Wenlong, Su, Huifang, Zhu, Wei‐Guo, Ji, Jianguo, Shen, Pingping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Full Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7675186/ https://www.ncbi.nlm.nih.gov/pubmed/33240752 http://dx.doi.org/10.1002/advs.202001417

Ejemplares similares

Intervening pyruvate carboxylase stunts tumor growth by strengthening anti-tumor actions of tumor-associated macrophages
por: Shu, Yuxin, et al.
Publicado: (2022)

Targeting CD44 Variant 5 with an Antibody–Drug Conjugate Is an Effective Therapeutic Strategy for Intrahepatic Cholangiocarcinoma
por: Bei, Yuncheng, et al.
Publicado: (2023)

Blockage of PPARγ T166 phosphorylation enhances the inducibility of beige adipocytes and improves metabolic dysfunctions
por: Yang, Nanfei, et al.
Publicado: (2022)

A novel mesenchymal stem cell-based regimen for acute myeloid leukemia differentiation therapy
por: Sun, Luchen, et al.
Publicado: (2023)

Caspase-1 cleaves PPARγ for potentiating the pro-tumor action of TAMs
por: Niu, Zhiyuan, et al.
Publicado: (2017)

Chimeric antigen receptor macrophage therapy for breast tumours mediated by targeting the tumour extracellular matrix
por: Zhang, Wenlong, et al.
Publicado: (2019)

Expression of four cancer-testis antigens in TNBC indicating potential universal immunotherapeutic targets
por: Xiao, Jie, et al.
Publicado: (2023)

Pre-treatment with the CDK4/6 inhibitor palbociclib improves the efficacy of paclitaxel in TNBC cells
por: Cretella, Daniele, et al.
Publicado: (2019)

Crosstalk between IL‐15Rα(+) tumor‐associated macrophages and breast cancer cells reduces CD8(+) T cell recruitment
por: Zhang, Wenlong, et al.
Publicado: (2022)

Cdh1 Deficiency Sensitizes TNBC Cells to PARP Inhibitors
por: Li, Junjun, et al.
Publicado: (2022)

PD-L1 Expression in TNBC: A Predictive Biomarker of Response to Neoadjuvant Chemotherapy?
por: Cerbelli, Bruna, et al.
Publicado: (2017)

Tissue Selection for PD-L1 Testing in Triple Negative Breast Cancer (TNBC)
por: Dobritoiu, Florin, et al.
Publicado: (2022)

Chemotherapy with ceramide in TNBC
por: Legembre, Patrick, et al.
Publicado: (2015)

GHRH-antagonists in TNBC
por: Engel, Jörg B.
Publicado: (2015)

Cripto-1 in TNBC
por: Castro, Nadia P, et al.
Publicado: (2015)

Simultaneously targeting cancer-associated fibroblasts and angiogenic vessel as a treatment for TNBC
por: Sharma, Malvika, et al.
Publicado: (2021)

BCAP31 drives TNBC development by modulating ligand-independent EGFR trafficking and spontaneous EGFR phosphorylation
por: Fu, Wenyan, et al.
Publicado: (2019)

Extracellular ATP promotes angiogenesis and adhesion of TNBC cells to endothelial cells via upregulation of CTGF
por: Zhou, Yan‐Ting, et al.
Publicado: (2022)

Redox‐Responsive Dual Drug Delivery Nanosystem Suppresses Cancer Repopulation by Abrogating Doxorubicin‐Promoted Cancer Stemness, Metastasis, and Drug Resistance
por: Liu, Jia, et al.
Publicado: (2019)

Concurrent targeting of BMI1 and CDK4/6 abrogates tumor growth in vitro and in vivo
por: Elango, Ramesh, et al.
Publicado: (2019)

TAZ maintains telomere length in TNBC cells by mediating Rad51C expression
por: Yang, Lu, et al.
Publicado: (2021)

The Landscape of Targeted Therapies in TNBC
por: Vagia, Elena, et al.
Publicado: (2020)

VISTA is associated with immune infiltration and predicts favorable prognosis in TNBC
por: Zhang, Mi, et al.
Publicado: (2022)

Neural Functions Play Different Roles in Triple Negative Breast Cancer (TNBC) and non-TNBC
por: Tan, Renbo, et al.
Publicado: (2020)

Combined angiogenesis and PD-1 inhibition for immunomodulatory TNBC: concept exploration and biomarker analysis in the FUTURE-C-Plus trial
por: Wu, Song-Yang, et al.
Publicado: (2022)

Targeting PD-1/PD-L1 in cancer immunotherapy: An effective strategy for treatment of triple-negative breast cancer (TNBC) patients
por: Kumar, Sunny, et al.
Publicado: (2022)

Transcriptional inhibition by CDK7/9 inhibitor SNS-032 abrogates oncogene addiction and reduces liver metastasis in uveal melanoma
por: Zhang, Jing, et al.
Publicado: (2019)

An efficient Pd–NHC catalyst system in situ generated from Na(2)PdCl(4) and PEG-functionalized imidazolium salts for Mizoroki–Heck reactions in water
por: Sun, Nan, et al.
Publicado: (2017)

High phosphorylated cyclin-dependent kinase 2 expression indicates poor prognosis of luminal androgen receptor triple-negative breast cancer: pCDK2 in luminal androgen receptor TNBC
por: Jin, Zining, et al.
Publicado: (2022)

Abrogation of IFN-γ Signaling May not Worsen Sensitivity to PD-1/PD-L1 Blockade
por: Vackova, Julie, et al.
Publicado: (2020)

Baicalein enhances immune response in TNBC by inhibiting leptin expression of adipocytes
por: Liu, Mengjie, et al.
Publicado: (2023)

The Evaluation of Cytotoxic Properties from CCB-2 Sugar Complexes Against TNBC and Non-TNBC Cells
por: Jenie, Riris Istighfari, et al.
Publicado: (2021)

PD-1 abrogates the prolonged persistence of CD8(+) CAR-T cells with 4-1BB co-stimulation
por: Li, Feng, et al.
Publicado: (2020)

Cdk5 Inhibitory Peptide Prevents Loss of Dopaminergic Neurons and Alleviates Behavioral Changes in an MPTP Induced Parkinson’s Disease Mouse Model
por: He, Rongni, et al.
Publicado: (2018)

Mapping the Tumor Microenvironment in TNBC and Deep Exploration for M1 Macrophages-Associated Prognostic Genes
por: Xu, Baojin, et al.
Publicado: (2022)

EZH2 inhibitors abrogate upregulation of trimethylation of H3K27 by CDK9 inhibitors and potentiate its activity against diffuse large B-cell lymphoma
por: Xie, Shao, et al.
Publicado: (2020)

FZD5 contributes to TNBC proliferation, DNA damage repair and stemness
por: Sun, Yu, et al.
Publicado: (2020)

The identification of a TNBC liver metastasis gene signature by sequential CTC‐xenograft modeling
por: Vishnoi, Monika, et al.
Publicado: (2019)

Highly Active and Stable Pt–Pd Alloy Catalysts Synthesized by Room‐Temperature Electron Reduction for Oxygen Reduction Reaction
por: Wang, Wei, et al.
Publicado: (2017)

Synthesis of 1-[bis(trifluoromethyl)phosphine]-1’-oxazolinylferrocene ligands and their application in regio- and enantioselective Pd-catalyzed allylic alkylation of monosubstituted allyl substrates
por: Lai, Zeng-Wei, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_460807namnus94h05ghhqnvlp9